by Paul Mampilly
The Sovereign Investor
In early 2009, if you bought biotech stocks, you would have made over 400% when the sector peaked in 2015. What was going on in early 2009 that would have clued you in that biotech stocks were going to be a good bet?
Barack Obama. That’s right: Barack Obama was inaugurated president of the United States in January 2009.
Sophisticated investors like me track presidential campaigns to see if a candidate might favor a group of stocks.
It wasn’t any great surprise to find that once Obama’s administration was good for biotech stocks.